EUVIMEDEUVIMED entdecken
Crossref

Hyperactivation of TRPV4 causes the hippocampal pyroptosis pathway and results in cognitive impairment in LPS-treated mice

Dongming Guo, Yang Xu, Yingge Wang, Xiaolin Zhong, Zhenghai Liu, Suyun Li, Xiaofan Xu, Jingwen Zhang, Tianqing Xiong, Wenyu Cao, Jingyan Liang

Behavioural Brain Research · 2023-02 · 439 · 114223

DOI: 10.1016/j.bbr.2022.114223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2023-02. Verfasst von Dongming Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Medical, Yangzhou University, 225009 Yangzhou, Jiangsu, China; Hengyang Medical School, University of South Chin…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cognitive Dysfunction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Natural Science Research of Jiangsu Higher Education Institutions of China, Graduate Research and Innovation Projects of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, a newly discovered proinflammatory programmed cell death, is involved in the regulation of cognitive dysfunction, such as Alzheimer's disease. Exploring potential drug targets that prevent pyroptotic procedures might benefit the development of a cure for these diseases. In the present study, we explored whether the transient receptor potential vanilloid 4 (TRPV4) blocker HC067047 and knockdown of TRPV4 in the hippocampus could improve cognitive behavior through the inhibition of pyroptosis in a mouse model developed using systemic administration of lipopolysaccharide (LPS). We found that systemic administration of HC067047 or knockdown of hippocampal TRPV4 prevented the activation of canonical and noncanonical pyroptosis in the hippocampus of LPS-treated mice. Consistent with the inhibition of the hippocampal pyroptosis pathway, a knockdown of hippocampal TRPV4 lowered expression of TNF-α, IL-1β, IL-18, and IL-6. Furthermore, we verified that the main pyroptosis cell type might be a neuron, indicated by reduced neuronal marker expression. Mechanically, we also found that knockdown of hippocampal TRPV4 might inhibit phosphorylation of CamkⅡα which results in NFκb mediated inflammasome reduction in the hippocampus of LPS-treated mice. More interestingly, mice intraperitoneally injected with HC067047 or the hippocampus injected with TRPV4 shRNA showed improved cognitive behavior, as indicated by the enhanced discrimination ratio in the NORT, NOPT, and SNPT. Collectively, we consider that HC067047 might be a small molecular drug that prevents pyroptosis, and TRPV4 could be an effective therapeutic target for preventing pyroptosis-induced cognitive dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCognitive DysfunctionAnimalsMiceHippocampusInflammasomesLipopolysaccharidesPyroptosisTRPV Cation ChannelsMorpholinesPyrroles

Stichwörter der Autor:innen

Cognitive dysfunctionHC067047NeuNPyroptosisTRPV4

Substanzen

Antineoplastic AgentsInflammasomesLipopolysaccharidesTRPV Cation ChannelsTrpv4 protein, mouseHC-067047MorpholinesPyrroles

Autor:innen und Institutionen

  • Institute of Translational Medicine, Medical, Yangzhou University, 225009 Yangzhou, Jiangsu, China; Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China.
  • Institute of Neuroscience, Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China.
  • Department of Neurology, Affiliated Hospital of Yangzhou University, 225009 Yangzhou, Jiangsu, China.
  • The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
  • Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China.
  • Institute of Translational Medicine, Medical, Yangzhou University, 225009 Yangzhou, Jiangsu, China.

Förderung

  • Natural Science Foundation of Hunan Province
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • Graduate Research and Innovation Projects of Jiangsu Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Guo, D., Xu, Y., Wang, Y., Zhong, X., Liu, Z., Li, S., Xu, X., Zhang, J., Xiong, T., Cao, W., & Liang, J. (2023). Hyperactivation of TRPV4 causes the hippocampal pyroptosis pathway and results in cognitive impairment in LPS-treated mice. Behavioural Brain Research, 439, 114223. https://doi.org/10.1016/j.bbr.2022.114223

Vancouver

Guo D, Xu Y, Wang Y, Zhong X, Liu Z, Li S, et al. Hyperactivation of TRPV4 causes the hippocampal pyroptosis pathway and results in cognitive impairment in LPS-treated mice. Behavioural Brain Research. 2023;439:114223. doi:10.1016/j.bbr.2022.114223

BibTeX
@article{Guo2023,
  author = {Guo, Dongming and Xu, Yang and Wang, Yingge and Zhong, Xiaolin and Liu, Zhenghai and Li, Suyun and Xu, Xiaofan and Zhang, Jingwen and Xiong, Tianqing and Cao, Wenyu and Liang, Jingyan},
  title = {Hyperactivation of TRPV4 causes the hippocampal pyroptosis pathway and results in cognitive impairment in LPS-treated mice},
  journal = {Behavioural Brain Research},
  year = {2023},
  volume = {439},
  pages = {114223},
  doi = {10.1016/j.bbr.2022.114223}
}
Kostenlos starten →